| Thomas A Eiseman, MD | |
|
25 N Winfield Road, Winfield, IL 60190 | |
| (630) 933-4700 | |
| (630) 933-4721 |
| Full Name | Thomas A Eiseman |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 25 N Winfield Road, Winfield, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073514360 | NPI | - | NPPES |
| 3631498336019001 | Other | IL | HFS GROUP PAYEE ID |
| P00884750 | Other | MEDICARE RAILROAD PTAN (INDIVIDUAL) | |
| 0222075 | Other | IL | BLUE CROSS GROUP ID |
| 036102548 | Medicaid | IL | |
| 206147 | Other | IL | MEDICARE GROUP PTAN |
| CA4748 | Other | MEDICARE RAILROAD PTAN (GROUP) | |
| 1033149844 | Other | IL | GROUP NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036102548 (Illinois) | Primary |
| 207R00000X | Internal Medicine | 036102548 (Illinois) | Secondary |
| Entity Name | Central Dupage Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619074028 PECOS PAC ID: 5597763706 Enrollment ID: O20061127000063 |
News Archive
Extracranial–intracranial bypass is a "durable" treatment option for giant middle cerebral artery aneurysms that cannot be clipped, say US researchers.
Despite tight government regulation, more than 200,000 visits are made annually to U.S. emergency departments for toy-related injuries. Parents and pediatric health providers are often unaware of how toys are assigned safety labels and suggestions for recommended age-appropriate use.
The American Society of Anesthesiologists (ASA) is taking action to educate parents about the increased risk of complications faced by obese children undergoing anesthesia. The number of obese children has doubled in the past two decades and tripled among adolescents and the ASA encourages parents to help improve both the surgical outcomes and long-term health of America's youth.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
The Times reports: "Women need more health care than men because of the combined demands of pregnancy and family planning. ... Partly as a result, young women typically must pay more than young men for individual health insurance, unless they live in one of 10 states where 'gender rating' is illegal.
› Verified 9 days ago
| Entity Name | Midwest Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952409765 PECOS PAC ID: 5698771848 Enrollment ID: O20070301000010 |
News Archive
Extracranial–intracranial bypass is a "durable" treatment option for giant middle cerebral artery aneurysms that cannot be clipped, say US researchers.
Despite tight government regulation, more than 200,000 visits are made annually to U.S. emergency departments for toy-related injuries. Parents and pediatric health providers are often unaware of how toys are assigned safety labels and suggestions for recommended age-appropriate use.
The American Society of Anesthesiologists (ASA) is taking action to educate parents about the increased risk of complications faced by obese children undergoing anesthesia. The number of obese children has doubled in the past two decades and tripled among adolescents and the ASA encourages parents to help improve both the surgical outcomes and long-term health of America's youth.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
The Times reports: "Women need more health care than men because of the combined demands of pregnancy and family planning. ... Partly as a result, young women typically must pay more than young men for individual health insurance, unless they live in one of 10 states where 'gender rating' is illegal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas A Eiseman, MD 25 N. Winfield Road, Winfield, IL 60190 Ph: (630) 933-4700 | Thomas A Eiseman, MD 25 N Winfield Road, Winfield, IL 60190 Ph: (630) 933-4700 |
News Archive
Extracranial–intracranial bypass is a "durable" treatment option for giant middle cerebral artery aneurysms that cannot be clipped, say US researchers.
Despite tight government regulation, more than 200,000 visits are made annually to U.S. emergency departments for toy-related injuries. Parents and pediatric health providers are often unaware of how toys are assigned safety labels and suggestions for recommended age-appropriate use.
The American Society of Anesthesiologists (ASA) is taking action to educate parents about the increased risk of complications faced by obese children undergoing anesthesia. The number of obese children has doubled in the past two decades and tripled among adolescents and the ASA encourages parents to help improve both the surgical outcomes and long-term health of America's youth.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
The Times reports: "Women need more health care than men because of the combined demands of pregnancy and family planning. ... Partly as a result, young women typically must pay more than young men for individual health insurance, unless they live in one of 10 states where 'gender rating' is illegal.
› Verified 9 days ago
Kevin J. Aister, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 N. Winfield Road, Winfield, IL 60190 Phone: 630-933-2640 | |
Meta Carroll, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-1602 | |
Dr. Matthew W Collander, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 North Winfield Rd, Central Dupage Hospital - Dept Of Emergency Medicine, Winfield, IL 60190 Phone: 630-933-2600 | |
Joseph Boyle, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 N. Winfield Road, Winfield, IL 60190 Phone: 630-933-2640 | |
Stephen Graham, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 N Winfield Road, Winfield, IL 60190 Phone: 630-933-2640 | |
Herbert Sutherland, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25 N. Winfield Road, Winfield, IL 60190 Phone: 630-933-2640 |